Published in J Gynecol Oncol on July 02, 2012
Diagnostic value of KLK6 as an ovarian cancer biomarker: A meta-analysis. Biomed Rep (2016) 0.75
Cancer statistics, 2004. CA Cancer J Clin (2004) 15.72
Cancer of the ovary. N Engl J Med (2004) 11.21
Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest (1981) 6.89
Serum protein markers for early detection of ovarian cancer. Proc Natl Acad Sci U S A (2005) 3.22
New tumor markers: CA125 and beyond. Int J Gynecol Cancer (2005) 2.92
Gene expression signature with independent prognostic significance in epithelial ovarian cancer. J Clin Oncol (2004) 2.91
CA 125: the past and the future. Int J Biol Markers (1999) 2.50
The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr Rev (2001) 2.47
The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer (2004) 2.38
Potential markers that complement expression of CA125 in epithelial ovarian cancer. Gynecol Oncol (2005) 2.34
Molecular aspects of tumor cell invasion and metastasis. Cancer (1993) 2.24
Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: a multivariate analysis of 704 patients [seecomments]. Ann Oncol (1997) 2.17
Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125. J Clin Oncol (1996) 1.91
Validation of serum biomarkers for detection of early-stage ovarian cancer. Am J Obstet Gynecol (2009) 1.90
The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metastasis (1992) 1.86
Early detection of ovarian cancer. Dis Markers (2007) 1.77
Proteases as prognostic markers in cancer. Clin Cancer Res (1996) 1.76
Human tissue kallikreins: a family of new cancer biomarkers. Clin Chem (2002) 1.42
Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma. J Clin Oncol (2003) 1.37
A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy. Clin Cancer Res (2007) 1.22
Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma. Clin Biochem (2000) 1.20
The role of CA 125 in screening for ovarian cancer. Int J Biol Markers (1999) 1.12
Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications. Clin Biochem (2000) 1.05
A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers. Cancer (1993) 1.04
Human tissue kallikrein gene family: applications in cancer. Cancer Lett (2005) 1.02
Savings obtained by CA-125 measurements during therapy for ovarian carcinoma. The North Thames Ovary Group. Eur J Cancer (1992) 1.02
Potential markers for detection and monitoring of ovarian cancer. J Oncol (2011) 1.01
Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma. Cancer Res (2002) 0.99
Future for ovarian cancer screening: novel markers from emerging technologies of transcriptional profiling and proteomics. J Natl Cancer Inst (2001) 0.96
Prognostic factors in ovarian carcinoma stage III patients. Can biomarkers improve the prediction of short- and long-term survivors? Int J Gynecol Cancer (2005) 0.93
Current initial therapy of stage III and IV ovarian cancer: challenges for managed care. Semin Oncol (1999) 0.92
Serum markers as prognostic factors in epithelial ovarian cancer: an overview. Eur J Gynaecol Oncol (2000) 0.92
Characterisation of human kallikrein 6/protease M expression in ovarian cancer. Br J Cancer (2004) 0.89
The association with age, human tissue kallikreins 6 and 10 and hemostatic markers for survival outcome from epithelial ovarian cancer. Arch Gynecol Obstet (2010) 0.87
Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients. Clin Cancer Res (2007) 0.85
Screening for ovarian cancer in the general population. Best Pract Res Clin Obstet Gynaecol (2005) 0.84
Prognostic factors in ovarian cancer. Cancer Treat Res (1998) 0.84
Prognosis of 2,800 patients with epithelial ovarian cancer diagnosed during 1975-94 and treated at the Norwegian Radium Hospital. Acta Obstet Gynecol Scand (1998) 0.82
Epidemiology of diabetic foot problems and predictive factors for limb loss. J Diabetes Complications (2008) 1.63
Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21. Proc Natl Acad Sci U S A (2012) 1.46
Noninvasive prenatal exclusion of haemoglobin Bart's using foetal DNA from maternal plasma. Prenat Diagn (2010) 1.44
Microsatellite markers within --SEA breakpoints for prenatal diagnosis of HbBarts hydrops fetalis. Clin Chem (2006) 1.41
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer. EMBO Mol Med (2013) 1.38
Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ). J Biomed Biotechnol (2009) 1.25
Database for exploration of functional context of genes implicated in ovarian cancer. Nucleic Acids Res (2008) 1.21
The potential of human fetal mesenchymal stem cells for off-the-shelf bone tissue engineering application. Biomaterials (2012) 1.10
Pre- and postnatal transplantation of fetal mesenchymal stem cells in osteogenesis imperfecta: a two-center experience. Stem Cells Transl Med (2013) 1.08
Neo-vascularization and bone formation mediated by fetal mesenchymal stem cell tissue-engineered bone grafts in critical-size femoral defects. Biomaterials (2009) 1.07
Authors' reply: Comment on authors' reply: Patients' perception of risk: informed choice in prenatal testing for foetal aneuploidy. Singapore Med J (2013) 1.06
Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer. Neoplasia (2007) 1.04
Microgel iron oxide nanoparticles for tracking human fetal mesenchymal stem cells through magnetic resonance imaging. Stem Cells (2009) 1.04
E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer. BMC Cancer (2010) 1.02
Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem/progenitor cells. Stem Cells (2013) 1.02
Stable human FIX expression after 0.9G intrauterine gene transfer of self-complementary adeno-associated viral vector 5 and 8 in macaques. Mol Ther (2011) 1.00
Human umbilical cord Wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro. J Cell Biochem (2012) 0.98
A study on Singaporean women's acceptance of using mobile phones to seek health information. Int J Med Inform (2011) 0.97
A biaxial rotating bioreactor for the culture of fetal mesenchymal stem cells for bone tissue engineering. Biomaterials (2009) 0.96
Cervical cancer prevention program in Jakarta, Indonesia: See and Treat model in developing country. J Gynecol Oncol (2012) 0.95
Human Wharton's jelly stem cells and its conditioned medium enhance healing of excisional and diabetic wounds. J Cell Biochem (2014) 0.94
Family centred decision making and non-disclosure of diagnosis in a South East Asian oncology practice. Psychooncology (2005) 0.94
Sonographic diagnosis and successful medical management of an intramural ectopic pregnancy. J Clin Ultrasound (2010) 0.93
Microcarrier culture for efficient expansion and osteogenic differentiation of human fetal mesenchymal stem cells. Biores Open Access (2013) 0.93
Predictive factors for lower extremity amputations in diabetic foot infections. Diabet Foot Ankle (2011) 0.92
RUNX3 functions as an oncogene in ovarian cancer. Gynecol Oncol (2011) 0.91
Noninvasive prenatal diagnosis of fetal aneuploidies and Mendelian disorders: new innovative strategies. Expert Rev Mol Diagn (2009) 0.90
Differential recovery of membrane proteins after extraction by aqueous methanol and trifluoroethanol. Proteomics (2007) 0.89
Psychological impact of the 2003 severe acute respiratory syndrome outbreak on health care workers in a medium size regional general hospital in Singapore. Occup Med (Lond) (2004) 0.88
Respiratory competent mitochondria in human ovarian and peritoneal cancer. Mitochondrion (2011) 0.88
Motivation, study habits, and expectations of medical students in Singapore. Med Teach (2009) 0.88
Contrasting effects of vasculogenic induction upon biaxial bioreactor stimulation of mesenchymal stem cells and endothelial progenitor cells cocultures in three-dimensional scaffolds under in vitro and in vivo paradigms for vascularized bone tissue engineering. Tissue Eng Part A (2012) 0.87
A multi-institutional survey on faculty development needs, priorities and preferences in medical education in an Asian medical school. Med Educ Online (2009) 0.86
Development of cell-selective films for layered co-culturing of vascular progenitor cells. Biomaterials (2009) 0.86
Assessment criteria for compliance with oral hygiene: application of ROC analysis. Oral Health Prev Dent (2007) 0.85
Morphologic quantification of the maxilla and the mandible with cone-beam computed tomography. Am J Orthod Dentofacial Orthop (2010) 0.85
Metabolic differences between Asian and Caucasian patients on clozapine treatment. Hum Psychopharmacol (2007) 0.85
The perception and intention to adopt female-focused healthcare applications (FHA): a comparison between healthcare workers and non-healthcare workers. Int J Med Inform (2008) 0.85
The case for intrauterine stem cell transplantation. Best Pract Res Clin Obstet Gynaecol (2012) 0.85
Influence of work environment on emotional health in a health care setting. Occup Med (Lond) (2004) 0.84
Vasculogenic and osteogenesis-enhancing potential of human umbilical cord blood endothelial colony-forming cells. Stem Cells (2012) 0.84
Extra-embryonic human Wharton's jelly stem cells do not induce tumorigenesis, unlike human embryonic stem cells. Reprod Biomed Online (2011) 0.83
Non-invasive prenatal diagnostic testing for β-thalassaemia using cell-free fetal DNA and next generation sequencing. Prenat Diagn (2014) 0.83
Membrane proteins of human fetal primitive nucleated red blood cells. J Proteomics (2012) 0.83
Same-day prenatal diagnosis of common chromosomal aneuploidies using microfluidics-fluorescence in situ hybridization. Prenat Diagn (2012) 0.83
Aurora-A expression, hormone receptor status and clinical outcome in hormone related cancers. Pathology (2010) 0.83
An exploratory study of ageing women's perception on access to health informatics via a mobile phone-based intervention. Int J Med Inform (2012) 0.83
microRNA-200b modulates microglia-mediated neuroinflammation via the cJun/MAPK pathway. J Neurochem (2014) 0.82
A nanoscaffold impregnated with human wharton's jelly stem cells or its secretions improves healing of wounds. J Cell Biochem (2014) 0.82
Pregnancy and H1N1 infection. Lancet (2009) 0.82
The use of microgel iron oxide nanoparticles in studies of magnetic resonance relaxation and endothelial progenitor cell labelling. Biomaterials (2010) 0.82
Human umbilical cord Wharton's jelly mesenchymal stem cells do not transform to tumor-associated fibroblasts in the presence of breast and ovarian cancer cells unlike bone marrow mesenchymal stem cells. J Cell Biochem (2012) 0.82
Silica-shell cross-linked micelles encapsulating fluorescent conjugated polymers for targeted cellular imaging. Biomaterials (2011) 0.82
The case for intrauterine gene therapy. Best Pract Res Clin Obstet Gynaecol (2012) 0.81
Asian society of gynecologic oncology workshop 2010. J Gynecol Oncol (2010) 0.81
Human Wharton's jelly stem cell conditioned medium enhances freeze-thaw survival and expansion of cryopreserved CD34+ cells. Stem Cell Rev (2013) 0.81
Human Wharton's jelly stem cells, its conditioned medium and cell-free lysate inhibit the growth of human lymphoma cells. Stem Cell Rev (2014) 0.81
Generalised convulsive status epilepticus in Singapore: clinical outcomes and potential prognostic markers. Seizure (2008) 0.81
A three dimensional anchorage independent in vitro system for the prolonged growth of embryoid bodies to study cancer cell behaviour and anticancer agents. Stem Cell Rev (2009) 0.80
Fetal gene therapy: recent advances and current challenges. Expert Opin Biol Ther (2011) 0.80
Comparison of risk of malignancy indices in evaluating ovarian masses in a Southeast Asian population. Singapore Med J (2013) 0.80
Beyond cell capture: antibody conjugation improves hemocompatibility for vascular tissue engineering applications. Tissue Eng Part A (2010) 0.80
In Silico discovery of transcription factors as potential diagnostic biomarkers of ovarian cancer. BMC Syst Biol (2011) 0.80
Lab-on-a-chip technology: impacting non-invasive prenatal diagnostics (NIPD) through miniaturisation. Lab Chip (2014) 0.79
Assessment of colour differences in silicone hand and digit prostheses: perceptible and acceptable thresholds for fair and dark skin shades. Prosthet Orthot Int (2006) 0.79
Maternal serum protein profile and immune response protein subunits as markers for non-invasive prenatal diagnosis of trisomy 21, 18, and 13. Prenat Diagn (2013) 0.78
Efficacy of metered-dose inhalers for children with acute asthma exacerbations. Pediatr Pulmonol (2010) 0.78
Expandability of haemopoietic progenitors in first trimester fetal and maternal blood: implications for non-invasive prenatal diagnosis. Prenat Diagn (2002) 0.78
Human keloid cell characterization and inhibition of growth with human Wharton's jelly stem cell extracts. J Cell Biochem (2014) 0.78
Human Wharton's jelly stem cell conditioned medium and cell-free lysate inhibit human osteosarcoma and mammary carcinoma cell growth in vitro and in xenograft mice. J Cell Biochem (2013) 0.78
Ovarian cancer proteomics: Many technologies one goal. Proteomics Clin Appl (2008) 0.77
Care of women in menopause: sexual function, dysfunction and therapeutic modalities. Ann Acad Med Singapore (2008) 0.77
Animal models for prenatal gene therapy: the nonhuman primate model. Methods Mol Biol (2012) 0.76
Separation of model mixtures of epsilon-globin positive fetal nucleated red blood cells and anucleate erythrocytes using a microfluidic device. J Chromatogr A (2010) 0.76
A prospective, randomized comparison of vaginal misoprostol versus intra-amniotic prostaglandins for midtrimester termination of pregnancy. Am J Obstet Gynecol (2005) 0.76
Re: embryonic and fetal globins are expressed in adult erythroid progenitor cells and in erythroid cell cultures (Lau et al., Prenat Diagn 2001; 21: 529-539). Prenat Diagn (2002) 0.75
Migration psychosis and homicide in Singapore: a five year study. Med Sci Law (2006) 0.75
Fetal diagnosis and therapy. Preface. Best Pract Res Clin Obstet Gynaecol (2012) 0.75
Application of porous membrane protected micro-solid-phase-extraction combined with gas chromatography-mass spectrometry for the determination of estrogens in ovarian cyst fluid samples. Anal Chim Acta (2010) 0.75
FlashFISH™: a novel technique for rapid diagnosis of aneuploidies in dysmorphic neonates. Clin Chem Lab Med (2014) 0.75
Fetal Treatment 2017: The Evolution of Fetal Therapy Centers - A Joint Opinion from the International Fetal Medicine and Surgical Society (IFMSS) and the North American Fetal Therapy Network (NAFTNet). Fetal Diagn Ther (2017) 0.75
Application of micro-solid-phase extraction for the determination of persistent organic pollutants in tissue samples. J Chromatogr A (2007) 0.75
Impact of Preoperative Serum Levels of CA 125 on Epithelial Ovarian Cancer Survival. Asian Pac J Cancer Prev (2016) 0.75
Serum-free media formulations are cell line-specific and require optimization for microcarrier culture. Cytotherapy (2015) 0.75
Novel approaches to manipulating foetal cells in the maternal circulation for non-invasive prenatal diagnosis of the unborn child. J Cell Biochem (2011) 0.75
Prenatal diagnosis of chromosomal abnormalities -- shifting paradigm. Ann Acad Med Singapore (2015) 0.75
A pilot study of the impact of the Asian Tsunami on a group of Asian media workers. Int J Emerg Ment Health (2005) 0.75
Preimplantation genetic diagnosis of chromosome translocations by analysis of polymorphic short tandem repeats. Singapore Med J (2012) 0.75
Establishing Prenatal Surgery for Myelomeningocele in Asia: The Singapore Consensus. Fetal Diagn Ther (2017) 0.75
Fetal sex discordance between sequencing-based and real-time PCR non-invasive prenatal test due to a vanishing twin. Clin Chem Lab Med (2016) 0.75
Tardive dyskinesia and impaired glucose tolerance. Hum Psychopharmacol (2002) 0.75
Application of real-time PCR of sex-independent insertion-deletion polymorphisms to determine fetal sex using cell-free fetal DNA from maternal plasma. Clin Chem Lab Med (2015) 0.75
Erratum: Human Wharton's Jelly Stem Cells and Its Conditioned Medium Enhance Healing of Excisional and Diabetic Wounds. J Cell Biochem (2017) 0.75
Stability of cell-free DNA from maternal plasma isolated following a single centrifugation step. Prenat Diagn (2014) 0.75
Erratum: A Nanoscaffold Impregnated With Human Wharton's Jelly Stem Cells or Its Secretions Improves Healing of Wounds. J Cell Biochem (2017) 0.75
Prenatal detection of isochromosome 21 by QF-PCR. A comparison between FISH and traditional karyotyping. Fetal Diagn Ther (2008) 0.75
Menopause, hormone therapy and cardiovascular and cerebrovascular disease. Ann Acad Med Singapore (2008) 0.75